stella
beta
Multimodal Deep Learning for Postoperative Liver Cancer Risk Stratification and Intervention — Stella
Recruiting
Back to Hepotacellular Carcinoma trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Tongji Hospital, Wuhan, Hubei
View full record on ClinicalTrials.gov